Ampio Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Ampio Pharmaceuticals's estimated annual revenue is currently $3.5M per year.
- Ampio Pharmaceuticals's estimated revenue per employee is $875,000
- Ampio Pharmaceuticals's total funding is $75.9M.
Employee Data
- Ampio Pharmaceuticals has 4 Employees.
- Ampio Pharmaceuticals grew their employee count by -43% last year.
What Is Ampio Pharmaceuticals?
Ampio Pharmaceuticals is a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options. We are developing compounds that serve significant medical needs in osteoarthritis, diabetic macular edema, and other prevalent, inflammatory diseases through an innovative discovery and development platform.
keywords:N/A
$75.9M
Total Funding
4
Number of Employees
$3.5M
Revenue (est)
-43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ampio Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO/Chairman | Reveal Email/Phone |
2 | EVP / Chief Financial Officer | Reveal Email/Phone |
3 | Contract Project Manager | Reveal Email/Phone |
4 | IT Manager | Reveal Email/Phone |
5 | VP Quality and Regulatory | Reveal Email/Phone |
6 | Director Program Management & Operations | Reveal Email/Phone |
7 | Chairman & CEO | Reveal Email/Phone |
Ampio Pharmaceuticals News
Ampio Pharmaceuticals (NYSE:AMPE) Research Coverage Started at StockNews.com. Posted by admin on Apr 24th, 2022. Share on Twitter Share on Facebook Share on...
Shares of Ampio Pharmaceuticals (NYSE American: AMPE) closed down 27% at $0.25 yesterday, as the US biopharma company announced the receipt...
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain...
ENGLEWOOD, CO, November 23, 2021 - Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it will host a conference call with its CEO and Chairman, Michael Martino, w ...
ENGLEWOOD, CO, September 21, 2021 - Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced regulatory approval from the Drugs Controller General of India (DCGI) of th ...
Other Companies in Centennial
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.3M | 4 | -20% | N/A |
#2 | $0.4M | 5 | 0% | N/A |
#3 | $0.4M | 5 | 0% | N/A |
#4 | $0.5M | 6 | 0% | N/A |
#5 | $0.4M | 6 | -14% | N/A |